Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 06-2006 | 06-2005 | 06-2004 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,962 | -38,189 | -39,978 | -40,620 | -24,825 |
| Depreciation Amortization | 7,544 | 6,855 | 6,092 | 5,766 | 5,275 |
| Accounts receivable | -15,933 | -5,698 | -5,486 | -2,947 | -7,286 |
| Accounts payable and accrued liabilities | 3,959 | -93 | 3,959 | -3,516 | 1,842 |
| Other Working Capital | -11,175 | -1,408 | 6,076 | 1,944 | -27,516 |
| Other Operating Activity | 24,716 | 10,506 | 6,033 | 8,493 | 5,970 |
| Operating Cash Flow | $-25,851 | $-28,027 | $-23,304 | $-30,880 | $-46,540 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,400 | -7,680 | -6,736 | -3,883 | -8,036 |
| Purchase Of Investment | -197,841 | -165,519 | -44,603 | -52,730 | -51,784 |
| Sale Of Investment | 162,480 | 100,470 | 70,956 | 25,487 | 50,707 |
| Other Investing Activity | 20 | -100 | -100 | -100 | -2,850 |
| Investing Cash Flow | $-46,741 | $-72,829 | $19,517 | $-31,226 | $-11,963 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 117,451 | 149,920 | 2,466 | 51,333 | 59,039 |
| Financing Cash Flow | $117,451 | $149,920 | $2,466 | $51,333 | $59,039 |
| Beginning Cash Position | 98,573 | 49,509 | 50,830 | 61,603 | 61,067 |
| End Cash Position | 143,432 | 98,573 | 49,509 | 50,830 | 61,603 |
| Net Cash Flow | $44,859 | $49,064 | $-1,321 | $-10,773 | $536 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,851 | -28,027 | -23,304 | -30,880 | -46,540 |
| Capital Expenditure | -11,400 | -7,680 | -6,736 | -3,883 | -8,036 |
| Free Cash Flow | -37,251 | -35,707 | -30,040 | -34,763 | -54,576 |